Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-23-073904

Director disposed of 3,435,480 shares (other)

  • Director acquired 812,076 shares (other)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2023-12-29 Other disposition : show line 1 in the form 10b5-1 −3,435,480 0 I
2023-12-29 Other acquisition : show line 2 in the form 10b5-1 +406,038 406,038 I
2023-12-29 Other acquisition : show line 3 in the form 10b5-1 +406,038 406,038 I
Loading xslF345X05/ownership.xml…